BCL2 and carcinoma: However, an increased rate of proliferation demonstrated using the Ki-67 index (>5%) correlates with an increased immunopositivity for p53, and EGFR and the loss of expression for Bcl-2 are aspects that rather support a diagnosis of carcinoma than a benign tumor [29,30].